Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for "ORPHAN DRUG|Designated|Treatment of multiple myeloma" in comments (approximate match)

Showing 31 - 40 of 65 results

First page
Previous page
4
Next page
Next page

TRYPSIN, UNSPECIFIED FORM

GV54A213NN

Status:

US Previously Marketed

Source:

Tryptar by Armour

(1951)

Source URL:

OB NME Appendix 1950-1985

First approved in 1951

Source:

Tryptar by Armour

Source URL:

OB NME Appendix 1950-1985

Class:

MIXTURE

Talquetamab

4W3KFI3TN3

Subunit 1 (452) Similarity Search Subunit 2 (445) Similarity Search Subunit 3 (215) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (452) Similarity Search Subunit 2 (445) Similarity Search Subunit 3 (215) Similarity Search Subunit 4 (214) Similarity Search

Status:

US Approved Rx (2023)

Source:

BLA761342

(2023)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761342

First approved in 2023

Source:

BLA761342

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761342

Class:

PROTEIN

Elranatamab

L0HR9A577V

Subunit 1 (447) Similarity Search Subunit 2 (441) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (215) Similarity Search

Sequence Search

Subunit 1 (447) Similarity Search Subunit 2 (441) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (215) Similarity Search

Status:

US Approved Rx (2023)

Source:

BLA761345

(2023)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761345

First approved in 2023

Source:

BLA761345

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761345

Class:

PROTEIN

CEVOSTAMAB

P86BHN01VE

Subunit 1 (450) Similarity Search Subunit 2 (449) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (219) Similarity Search

Sequence Search

Subunit 1 (450) Similarity Search Subunit 2 (449) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (219) Similarity Search

Status:

Investigational

Source:

NCT03275103: Phase 1 Interventional Active, not recruiting Multiple Myeloma

(2017)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03275103

Class:

PROTEIN

Podentamig

ZT35532VPU

Subunit 1 (507) Similarity Search

Sequence Search

Subunit 1 (507) Similarity Search

Status:

Investigational

Source:

INN:podentamig [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/ZT35532VPU

Class:

PROTEIN

Bezetabart Debotansine

0D8BWL78LD

Subunit 1 (454) Similarity Search Subunit 2 (454) Similarity Search Subunit 3 (215) Similarity Search Subunit 4 (215) Similarity Search

Sequence Search

Subunit 1 (454) Similarity Search Subunit 2 (454) Similarity Search Subunit 3 (215) Similarity Search Subunit 4 (215) Similarity Search

Status:

Investigational

Source:

NCT03424603: Phase 1 Interventional Completed B-cell Lymphoma

(2018)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03424603

Class:

PROTEIN

PAVURUTAMAB

GLR3JG8TZU

Subunit 1 (986) Similarity Search

Sequence Search

Subunit 1 (986) Similarity Search

Status:

Investigational

Source:

NCT03287908: Phase 1 Interventional Terminated Relapsed/Refractory Multiple Myeloma

(2017)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03287908

Class:

PROTEIN

ALNUCTAMAB

7OSV6M6T4D

Subunit 1 (671) Similarity Search Subunit 2 (446) Similarity Search Subunit 3 (216) Similarity Search Subunit 4 (216) Similarity Search Subunit 5 (232) Similarity Search

Sequence Search

Subunit 1 (671) Similarity Search Subunit 2 (446) Similarity Search Subunit 3 (216) Similarity Search Subunit 4 (216) Similarity Search Subunit 5 (232) Similarity Search

Status:

Investigational

Source:

NCT03486067: Phase 1 Interventional Active, not recruiting Multiple Myeloma

(2018)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03486067

Class:

PROTEIN

BERSANLIMAB

MP3N1L4OR6

Subunit 1 (447) Similarity Search Subunit 2 (447) Similarity Search Subunit 3 (217) Similarity Search Subunit 4 (217) Similarity Search

Sequence Search

Subunit 1 (447) Similarity Search Subunit 2 (447) Similarity Search Subunit 3 (217) Similarity Search Subunit 4 (217) Similarity Search

Status:

Investigational

Source:

NCT01025206: Phase 1 Interventional Completed Multiple Myeloma

(2009)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01025206

Class:

PROTEIN

Maplirpacept

44D51T6SZH

Subunit 1 (347) Similarity Search Subunit 2 (347) Similarity Search

Sequence Search

Subunit 1 (347) Similarity Search Subunit 2 (347) Similarity Search

Status:

Investigational

Source:

NCT03530683: Phase 1 Interventional Terminated Lymphoma

(2018)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03530683

Class:

PROTEIN

Mixture

TRYPSIN, UNSPECIFIED FORM

Protein

Protein

Protein

Protein

Protein

Bezetabart Debotansine

Protein

Protein

Protein

Protein

Showing 31 - 40 of 65 results

First page
Previous page
4
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1